ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.As of 25 May 2026, Zim Laboratories share price is ₹99.45. The stock opened at ₹99.50, compared to its previous close of ₹100.16. During today's trading session, Zim Laboratories share price moved in the range of ₹98.01 to ₹102.50, with an average price of ₹100.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹98.01 and a high of ₹102.50. On the performance front, Zim Laboratories share price has increased by 36.59% over the last six months and is up 9.43% on a year-on-year basis.
The market capitalization of Zim Laboratories is ₹536 Crs, with a P/E ratio of 91.8 and a dividend yield of 0.00%.